Delivery of Galanin-Like Peptide to the Brain: Targeting with Intranasal Delivery and Cyclodextrins
Authors:
- Susan A. FarrSFSusan A. Farr
- Haruaki KageyamaHKHaruaki Kageyama
- Seiji ShiodaSSSeiji Shioda
- William A. BanksWBWilliam A. Banks
- 1 May 2008
- journal article
- research article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 325 (2) , 513-519
Abstract
Galanin-like peptide (GALP) shows potential as a therapeutic in the treatment of obesity and related conditions. In this study, we compared the uptake by brain regions and peripheral tissues of radioactively iodinated GALP (I-GALP) after intranasal (i.n.), i.v., and i.c.v. administration. I-GALP was stable in blood and brain during the 10-min study time regardless of route of administration, and similar levels were achieved in cerebrospinal fluid after i.v. and i.n. administration. However, levels in most brain regions were approximately 4 to 10 times higher and uptake by spleen, representative of peripheral tissues, approximately 10% as high after i.n. than i.v. administration. Thus, i.n. administration provided about a 40- to 100 fold improvement in targeting brain versus peripheral tissues compared with i.v. administration. Uptake of I-GALP by whole brain after i.n. administration was inhibited by approximately 50% by 1 μg/mouse of unlabeled GALP, thus demonstrating a saturable component to uptake. Combining I-GALP with cyclodextrins increased brain uptake approximately 3-fold. Selectivity for brain region uptake was also seen with route of administration and with use of cyclodextrins. The hippocampus had the greatest uptake after i.c.v. administration, the cerebellum after i.v. administration, the hypothalamus with i.n. administration without cyclodextrins, the hypothalamus and olfactory bulb (OB) after i.n. administration with α-cyclodextrin, and the OB after i.n. administration with dimethyl-β cyclodextrin. These studies show that intranasal administration is an effective route of administration for the delivery of GALP to the brain and that targeting among brain regions may be possible with the use of various cyclodextrins.Keywords
This publication has 22 references indexed in Scilit:
- Intranasal insulin improves memory in humansPsychoneuroendocrinology, 2004
- Brain Uptake of the Glucagon-Like Peptide-1 Antagonist Exendin(9-39) after Intranasal AdministrationThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Glucagon-like peptide-1 receptor is involved in learning and neuroprotectionNature Medicine, 2003
- Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to ratsInternational Journal of Pharmaceutics, 2003
- Sniffing neuropeptides: a transnasal approach to the human brainNature Neuroscience, 2002
- Galanin receptor subtypesTrends in Pharmacological Sciences, 2000
- Contribution of extracranial lymphatics and arachnoid villi to the clearance of a CSF tracer in the ratAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 1999
- Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new viewImmunology Today, 1992
- Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkeyJournal of Comparative Neurology, 1986
- Transneuronal transport of peroxidase-conjugated wheat germ agglutinin (WGA-HRP) from the olfactory epithelium to the brain of the adult ratExperimental Brain Research, 1986